Yeji
AdComconf 0.85

omecamtiv mecarbil — AdCom

$CYTK · CYTOKINETICS INC · heart failure with reduced ejection fraction (HFrEF)
Event date
Date TBD
Sponsor runway
3 mo
$129.8M liquid

Evidence

the Agency plans to convene an Advisory Committee meeting for the New Drug Application (NDA) for omecamtiv mecarbil. Cytokinetics expects the FDA to inform it of the date and topics for the Advisory Committee Meeting in a subsequent communication.
Source: 8-K filed 2022-05-17View on EDGAR ↗0001171843-22-003762

Comparable historical adcoms· last 5 years · same event type

No comparable historical outcomes in our database yet — backfill of past readouts arrives next ingestion cycle.

Recent insider activity· ±90 days

11 insiders · 0 buys · 29 sells
Exercise10b5-1
2026-05-19
Malik Fady Ibraham
EVP Research & Development
3,500 @ $7.80$27K
Sell10b5-1
2026-05-19
Malik Fady Ibraham
EVP Research & Development
3,500 @ $75.69$265K
Sell10b5-1
2026-05-14
Blum Robert I
President & CEO
7,500 @ $77.92$584K
Sell10b5-1
2026-05-05
Callos Andrew
EVP, Chief Commercial Officer
11,333 @ $77.25$875K
Exercise10b5-1
2026-05-05
Callos Andrew
EVP, Chief Commercial Officer
11,333 @ $39.13$443K
Sell10b5-1
2026-05-05
HENDERSON JOHN T
Director
20,000 @ $75.97$1.52M
Exercise10b5-1
2026-05-05
WIERENGA WENDELL
Director
4,032 @ $12.40$50K
Sell10b5-1
2026-05-05
WIERENGA WENDELL
Director
4,032 @ $75.00$302K
Exercise10b5-1
2026-05-05
Malik Fady Ibraham
EVP Research & Development
3,500 @ $7.80$27K
Sell10b5-1
2026-05-05
Lee Sung
EVP, Chief Financial Officer
23,906 @ $76.87$1.84M
Sell10b5-1
2026-05-05
Malik Fady Ibraham
EVP Research & Development
3,500 @ $77.37$271K
Exercise10b5-1
2026-05-05
HENDERSON JOHN T
Director
20,000 @ $7.61$152K
Exercise10b5-1
2026-05-01
Callos Andrew
EVP, Chief Commercial Officer
15,857 @ $37.63$597K
Sell10b5-1
2026-05-01
Callos Andrew
EVP, Chief Commercial Officer
15,857 @ $65.00$1.03M
Sell10b5-1
2026-04-30
Callos Andrew
EVP, Chief Commercial Officer
15,000 @ $63.26$949K
Exercise10b5-1
2026-04-30
Callos Andrew
EVP, Chief Commercial Officer
15,000 @ $23.26$349K
Sell10b5-1
2026-04-29
Blum Robert I
President & CEO
7,500 @ $59.62$447K
Exercise10b5-1
2026-04-21
Malik Fady Ibraham
EVP Research & Development
3,500 @ $7.80$27K
Sell10b5-1
2026-04-21
Malik Fady Ibraham
EVP Research & Development
3,500 @ $65.69$230K
Sell10b5-1
2026-04-15
Blum Robert I
President & CEO
7,500 @ $65.38$490K
Sell10b5-1
2026-04-15
Callos Andrew
EVP, Chief Commercial Officer
7,449 @ $66.02$492K
Grant
2026-04-15
Daly James M
Director
191 @ $65.37$12K
Grant
2026-04-15
Wysenski Nancy
Director
95 @ $65.37$6K
Grant
2026-04-15
HENDERSON JOHN T
Director
325 @ $65.37$21K
Grant
2026-04-15
WIERENGA WENDELL
Director
95 @ $65.37$6K
Grant
2026-04-15
Kaye Edward M. MD
Director
191 @ $65.37$12K
Grant
2026-04-15
Harrington Robert Arthur
Director
191 @ $65.37$12K
Sell10b5-1
2026-04-07
Malik Fady Ibraham
EVP Research & Development
1,000 @ $64.75$65K
Exercise10b5-1
2026-04-07
Malik Fady Ibraham
EVP Research & Development
1,000 @ $10.60$11K
Sell10b5-1
2026-04-07
Malik Fady Ibraham
EVP Research & Development
3,500 @ $65.21$228K
Exercise10b5-1
2026-04-07
Malik Fady Ibraham
EVP Research & Development
3,500 @ $7.80$27K
Sell10b5-1
2026-04-01
Blum Robert I
President & CEO
7,500 @ $66.63$500K
Sell10b5-1
2026-03-31
Callos Andrew
EVP, Chief Commercial Officer
3,639 @ $65.00$237K
Sell10b5-1
2026-03-18
Callos Andrew
EVP, Chief Commercial Officer
1,930 @ $62.07$120K
Sell
2026-03-17
Malik Fady Ibraham
EVP Research & Development
7,636 @ $62.15$475K
Sell
2026-03-17
Callos Andrew
EVP, Chief Commercial Officer
2,916 @ $62.15$181K
Sell
2026-03-17
Lee Sung
EVP, Chief Financial Officer
4,935 @ $62.15$307K
Sell
2026-03-17
Blum Robert I
President & CEO
23,928 @ $62.15$1.49M
Sell
2026-03-17
Blum Robert I
President & CEO
12,673 @ $62.15$788K
Sell
2026-03-17
Callos Andrew
EVP, Chief Commercial Officer
5,626 @ $62.15$350K
Sell
2026-03-17
Malik Fady Ibraham
EVP Research & Development
4,397 @ $62.15$273K
Sell10b5-1
2026-03-16
Callos Andrew
EVP, Chief Commercial Officer
1,709 @ $61.03$104K
Grant
2026-03-15
Lee Sung
EVP, Chief Financial Officer
29,480 @
Grant
2026-03-15
Malik Fady Ibraham
EVP Research & Development
27,306 @
Grant
2026-03-15
Malik Fady Ibraham
EVP Research & Development
1,665 @
Grant
2026-03-15
Malik Fady Ibraham
EVP Research & Development
39,527 @
Grant
2026-03-15
Blum Robert I
President & CEO
75,258 @
Grant
2026-03-15
Blum Robert I
President & CEO
1,665 @
Grant
2026-03-15
Blum Robert I
President & CEO
111,864 @
Grant
2026-03-15
Hessekiel Jeffrey
Chief Legal & Admin Officer
20,646 @
+ 11 more